Itaconate

Itaconate

SCHEMBL107045

C=C(CC(=O)[O-])C(=O)[O-].[K+].[K+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Itaconate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.53
CASP1 P29466 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
FAHD1 Q6P587 1/20 0.33
FFAR3 O14843 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Itaconate SCHEMBL11692447 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL3209006 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL108568 0.97 CA4 (0.56) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL9244087 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL2523981 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL18554541 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL7518248 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL7511457 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL106714 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2
Itaconate SCHEMBL18554414 0.97 CA4 (0.50) CA4CASP1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119591805-A Early-strength polycarboxylate superplasticizer with thickening and water-retaining properties and preparation method thereof 中建西部建设新材料科技有限公司 2025-03-11 CN claimed
CN-119569957-A Polycarboxylate superplasticizer and preparation method and application thereof 科之杰新材料集团有限公司 2025-03-07 CN claimed
CN-119463055-A Polycarboxylic acid slump retaining agent and preparation method and application thereof 科之杰新材料集团有限公司 2025-02-18 CN claimed
US-20230149899-A1 POROUS SUPERABSORBENT POLYMER MATERIAL FOR MICROALGAE HARVESTING GEORGIA TECH RESEARCH CORPORATION 2023-05-18 US claimed
US-20230093653-A1 NUCLEATED POLYOLEFIN COMPOSITIONS AND METHODS AND USES THEREOF BRASKEM S.A. (BR) 2023-03-23 US claimed
US-11499039-B2 Nucleated polyolefin compositions and methods and uses thereof BRASKEM S.A. (BR) 2022-11-15 US claimed
CN-111218036-A Preparation process for improving folding resistance of leisure sole material 界首市盛泽鞋业有限公司 2020-06-02 CN claimed
CN-111056817-A Preparation method of environment-friendly coal gangue-based hollow brick 和县明生环保材料有限责任公司 2020-04-24 CN claimed
US-20190225781-A1 NUCLEATED POLYOLEFIN COMPOSITIONS AND METHODS AND USES THEREOF BRASKEM S.A. (BR) 2019-07-25 US claimed
EP-3481874-A1 NUCLEATED POLYOLEFIN COMPOSITIONS AND METHODS AND USES THEREOF Braskem S.A. (BR) 2019-05-15 EP claimed
CN-107405288-A The polymer of itaconic acid and its purposes in cosmetic product or personal care product as film forming agent 伊塔康尼克(英国)有限公司 2017-11-28 CN claimed
US-20160250134-A1 POLYMERS AND USES THEREOF REVOLYMER (U.K.) LIMITED (GB) 2016-09-01 US claimed
CN-105624819-A Preparation method of hydrophilic polyacrylonitrile-based carbon fiber precursor CHINA PETROLEUM & CHEM CORP 2016-06-01 CN claimed
WO-2016075498-A1 POLYMERS OF ITACONIC ACID AND USES THEREOF AS A FILM FORMING AGENT IN A COSMETIC OR PERSONAL CARE PRODUCT REVOLYMER (U.K.) LIMITED (GB) 2016-05-19 WO claimed
CN-103374854-B A kind of papermaking filler special and the paper containing this filler LI RUJI (CN) 2015-11-04 CN claimed
CN-104815841-A Heavy metal polluted soil in-situ chromatography governance method BEIJING TAIKEMEI HI TECH CO LTD 2015-08-05 CN claimed
CN-103374854-A Specific papermaking filling and paper containing same LI RUJI 2013-10-30 CN claimed
US-4345006-A Method of treating leather ROHM GMBH (DE) 1982-08-17 US claimed
US-4040970-A WITH COPOLYMER FOR RENDERING THE TONER NEGATIVELY CHARGEABLE CANON KABUSHIKI KAISHA (JA) 1977-08-09 US claimed
US-3977983-A Liquid developer for use in development of an electrostatic latent image comprising a copolymer containing an amino group converted into a quaternary ammonium salt or hydroxide CANON KABUSHIKI KAISHA (JA) 1976-08-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160250134-A1 POLYMERS AND USES THEREOF SUCLG1, CUTA, ETF1 CA4 2913/4885CASP1 2876/4885CA12 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.